-+ 0.00%
-+ 0.00%
-+ 0.00%

Cytokinetics CEO Robert I. Blum disposes of 7,500 common shares for $606,525

PUBT·07/27/2026 20:34:34
Listen to the news
Cytokinetics CEO Robert I. Blum disposes of 7,500 common shares for $606,525
  • Cytokinetics President and CEO Robert I. Blum exercised 7,500 non-qualified stock options at USD 10.6 on July 27, 2026.
  • Blum sold 7,500 shares at USD 80.87 on the same day.
  • Directly held common stock fell to 377,820 shares following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytokinetics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001061983-26-000085), on July 27, 2026, and is solely responsible for the information contained therein.